← Eichor
Study identifier: NCT04292054 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)

Condition: Burns Surgery  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhasePhase 3
Planned participants506
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The indication of antibiotic prophylaxis in burn patients remains highly controversial and hasn't reached a consensus. The objective of antibiotic prophylaxis would be to reduce the risk of post-operative local and systemic infections. Burn surgery is associated with a high risk of bacteremia and postoperative infections and sepsis. However, antibiotic prophylaxis exposes to the risk of selecting drug-resistant pathogens as well as adverse effects of antibiotics (i.e Clostridium difficile colitis). Recommendations regarding perioperative prophylaxis using systemic antibiotics vary across sources. The lack of data precludes any international strong recommendations regarding the best strategy regarding antibiotic prophylaxis. The goal of this project is therefore to determine whether peri-operative systemic antibiotics prophylaxis could reduce the incidence of post-operative infections in burn patients.

This description comes directly from the study's public registry record.

Talk to the study team

François DEPRET, MD  ·  01 42 49 95 70  ·  francois.depret@aphp.fr

Matthieu LEGRAND, MD-PhD  ·  01 42 49 95 70  ·  matthieu.m.legrand@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Saint Louis HospitalParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04292054